Docetaxel Resistance in Prostate Cancer: Taking It Up a Notch.
作者:
Zhang(Tian),Armstrong(Andrew J)
状态:
发布时间2015-10-16
, 更新时间 2015-10-16
期刊:
Clin Cancer Res
摘要:
Notch signaling is implicated in prostate cancer progression and docetaxel resistance. Cui and colleagues describe the additive efficacy and mechanisms of a γ-secretase inhibitor, PF-03084014, and docetaxel in preclinical models of prostate cancer, suggesting the need for further clinical development of Notch pathway modulators in men with metastatic prostate cancer.